Encompass Health Overview
Encompass Health Target Price
See Encompass Health's analyst price targets ($150) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$122.1
Average Target Price
$148.20
21.4% upside
21.4% upside5 analysts in the last 4 months
High: $155 | Low: $140
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-07 | Truist FinancialDavid MacDonald | $150 | 22.9% upside |  |
| 2026-08-07 | UBS | $155 | 26.9% upside | |
| 2026-08-06 | Barclays | $144 | 17.9% upside | |
| 2026-05-22 | Leerink PartnersWhit Mayo | $152 | 24.5% upside | |
| 2026-05-05 | Barclays | $140 | 14.7% upside | |
| 2026-02-06 | Barclays | $153 | 25.3% upside | |
| 2025-10-30 | BarclaysAndrew Mok | $150 | 22.9% upside | |
| 2025-10-02 | UBS | $150 | 22.9% upside | |
| 2025-08-14 | Truist FinancialDavid MacDonald | $140 | 14.7% upside | |
| 2025-04-28 | RBC Capital | $125 | 2.4% upside | |
| 2024-09-26 | RBC CapitalBen Hendrix | $105 |  14% downside | |
| 2024-09-25 | UBSAJ Rice | $110 | 9.9% downside | |
| 2024-05-22 | RBC CapitalFrank Morgan | $95 | 22.2% downside | |
| 2024-04-25 | Mizuho SecuritiesAnn Hynes | $95 | 22.2% downside | |
| 2024-03-28 | BarclaysAndrew Mok | $101 | 17.3% downside | |
| 2022-05-03 | RBC Capital | $85 | 30.4% downside | |
| 2022-05-02 | Raymond James | $85 | 30.4% downside | |
| 2022-04-29 | Credit Suisse | $83 | 32% downside | |
| 2021-04-29 | StephensScott Fidel | $100 | 18.1% downside | |